Difference between revisions of "Azign Biosciences"
From Biolecture.org
| Line 1: | Line 1: | ||
Gone down now?<br /> | Gone down now?<br /> | ||
<br /> | <br /> | ||
| + | <span class="h1">Azign Bioscience A/S sells licensing rights and focuses its strategy on genomic technologies for the development of drugs and diagnostics</span><br /> | ||
| + | <br /> | ||
| + | <span class="h2">28 May 2001 <br /> | ||
| + | </span><br /> | ||
| + | <br /> | ||
| + | <br /> | ||
| + | <a href="http://ns.net.dynamicweb.dk/Default.aspx?ID=489&M=News&PID=2914&NewsID=14720">http://ns.net.dynamicweb.dk/Default.aspx?ID=489&M=News&PID=2914&NewsID=14720</a> | ||
Latest revision as of 13:53, 15 January 2008
Gone down now?
Azign Bioscience A/S sells licensing rights and focuses its strategy on genomic technologies for the development of drugs and diagnostics
28 May 2001
http://ns.net.dynamicweb.dk/Default.aspx?ID=489&M=News&PID=2914&NewsID=14720
